Litcius/Paper detail

Lack of N-glycosylation increases amyloidogenic processing of the amyloid precursor protein

Lin Tong, Lea S. van Husen, Yang Yu, Lars O. Tjernberg, Sophia Schedin‐Weiss

2022Glycobiology16 citationsDOIOpen Access PDF

Abstract

The amyloid precursor protein (APP) is a ubiquitously expressed type 1 transmembrane protein mostly known for serving as a precursor to the amyloid-β peptide (Aβ), a culprit in Alzheimer disease (AD). However, APP also has important physiological functions by being implicated in, for instance, adhesion, signaling, neuronal development, and synaptic function. Human APP contains 2 N-glycosylation sites, at asparagine (N) 467 (N467) and N496. Here, we studied the role of N-glycosylation on APP trafficking and processing by constructing APP-SNAP plasmid vectors for wildtype APP and N-glycosylation site mutants in which N467 or N496 was replaced by glutamine (Q) and expressed these in HEK293T cells. Lack of either of the 2 N-glycans resulted in a reduction in the size of intracellular APP-SNAP-positive vesicles and a reduction of APP-SNAP in the plasma membrane and lysosomes. Importantly, loss of either of the 2 N-glycans resulted in elevated levels of intracellular as well as secreted Aβ42. These data suggest that N-glycans have a major impact on trafficking and processing of APP and could play an important role in the development of AD.

Topics & Concepts

Amyloid precursor proteinGlycosylationP3 peptideChemistryIntracellularTransmembrane proteinN-linked glycosylationCell biologyAsparagineGlycanBiochemistryAlpha secretaseGlycoproteinAlzheimer's diseaseBiologyAmino acidDiseaseMedicineReceptorPathologyAlzheimer's disease research and treatmentsGlycosylation and Glycoproteins ResearchAmyloidosis: Diagnosis, Treatment, Outcomes